Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders.

Source:http://linkedlifedata.com/resource/pubmed/id/18383321

Download in:

View as

General Info

PMID
18383321